Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Immunotherapy with Intralesional Vitamin D Injection in Recalcitrant Wart at a Tertiary Care Center: A Descriptive Cross-sectional Study

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Immunotherapy with Intralesional Vitamin D Injection in Recalcitrant Wart at a Tertiary Care Center: A Descriptive Cross-sectional Study

Source: Article title.

An informed consent from each patients was sought prior to commencement of treatment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Immunotherapy with Intralesional Vitamin D Injection in Recalcitrant Wart at a Tertiary Care Center: A Descriptive Cross-sectional Study

Cross-sectional study · JNMA: Journal of the Nepal Medical Association · 2024

Original publication title

Immunotherapy with Intralesional Vitamin D Injection in Recalcitrant Wart at a Tertiary Care Center: A Descriptive Cross-sectional Study

Eliz Aryal; Jyoti Bhari; Prashanna Raj Shrestha

© The Author(s) 2024.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Intralesional administration of Vitamin D is an effective treatment option for reclacitrant warts and is, highly effective, cost-efficient, with minimal adverse effects, and can be perfomed in our clinical set up.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Recalcirant warts are resistant to conventional therapeutic option with high recurrence rate. In recent year, treatment of warts with different immunotherapeutic agent has shown good results, as it regulate epidermal cell proliferation and are involved in the formation of anti microbial peptides. Hence, this study was undertaken to evaluate the efficacy of immunotherapy with intralesional vitamin D in wart.

Source: Introduction:

Abstract: What methods does the paper describe?

A descriptive cross-sectional study was conducted from 1st January 2021 to 2nd February 2023 at Kathmandu Medical College after approval from the Institutional Review Committee (Reference number: 0110202002). Ninety: two patients with recalcitrant wart of varying sizes and duration were included in the study. Injection vitamin D ( 600000 IU, 15mg/ml) was injected about (0.2-0.5 ml) to the base of the wart. Maximum of five warts were injected per month, and was repeated after 4 weeks for 3 sessions.

Source: Methods:

Abstract: Results

Among 92 patient, complete response was seen in 70 patient (76.08%), partial response was seen in 17 patients ( 18.47%) and 5 patient (5.43%)showed no response. Mild pain as observed at the time of injection. Signs of hypervitaminosis D was not observed.

Source: Results:

Abstract: Conclusions

Intralesional administration of Vitamin D is an effective treatment option for reclacitrant warts and is, highly effective, cost-efficient, with minimal adverse effects, and can be perfomed in our clinical set up.

Source: Conclusions:
Authors’ abstract

ABSTRACT

Introduction:

Recalcirant warts are resistant to conventional therapeutic option with high recurrence rate. In recent year, treatment of warts with different immunotherapeutic agent has shown good results, as it regulate epidermal cell proliferation and are involved in the formation of anti microbial peptides. Hence, this study was undertaken to evaluate the efficacy of immunotherapy with intralesional vitamin D in wart.

Methods:

A descriptive cross-sectional study was conducted from 1st January 2021 to 2nd February 2023 at Kathmandu Medical College after approval from the Institutional Review Committee (Reference number: 0110202002). Ninety: two patients with recalcitrant wart of varying sizes and duration were included in the study. Injection vitamin D ( 600000 IU, 15mg/ml) was injected about (0.2-0.5 ml) to the base of the wart. Maximum of five warts were injected per month, and was repeated after 4 weeks for 3 sessions.

Results:

Among 92 patient, complete response was seen in 70 patient (76.08%), partial response was seen in 17 patients ( 18.47%) and 5 patient (5.43%)showed no response. Mild pain as observed at the time of injection. Signs of hypervitaminosis D was not observed.

Conclusions:

Intralesional administration of Vitamin D is an effective treatment option for reclacitrant warts and is, highly effective, cost-efficient, with minimal adverse effects, and can be perfomed in our clinical set up.

Publication and source details

Original title: Immunotherapy with Intralesional Vitamin D Injection in Recalcitrant Wart at a Tertiary Care Center: A Descriptive Cross-sectional Study

Eliz Aryal; Jyoti Bhari; Prashanna Raj Shrestha

JNMA: Journal of the Nepal Medical Association · 2024

Correspondence: Dr. Eliz Aryal, Department of Dermatology, kathmandu medical college and teaching Hospital, Sinamangal, Kathmandu, Nepal. Email: eliz_aryal@yahoo.com, Phone: +977-9849214203.© The Author(s) 2024.2024https://creativecommons.org/licenses/by/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:59:45.740730+00:00

DOI: 10.31729/jnma.8614 · PMC11185302